Feature | Cardiovascular Business | April 03, 2023 | By Melinda Taschetta-Millane

Top 10: What Viewers were reading in March

Here's a look at what viewers found most interesting during the month of March

Here's a look at what viewers found most interesting during the month of March

In the blink of an eye yet another month has passed, and here is a look at the Top 10 of what DIcardiology.com viewers found to be most interesting during the month of March.

1. Biological Clock Shock? “Springing Forward” May Have Drawbacks For Heart Health

2. STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports

3. Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial

4. Study Shows One in 25 Patients Undergoing Transesophageal Echocardiography-guided Transcatheter Structural Cardiac Intervention Suffered a Major Complication

5. DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology

6. New Ablation Technology Found Safe, Effective for Atrial Fibrillation

7. GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC

8. American College of Cardiology (ACC) Champions Distinguished Awards Winners at ACC.23/WCC Convocation

9. Virtual Care Team-Guided Strategy Optimizes GDMT for Hospitalized HF Patients in IMPLEMENT-HF Trial, According to Multi-Center Study Presented at ACC 23

10. CLEAR Trial Reported at ACC23 Finds Bempedoic Acid Lowers LDL Cholesterol, Reduces Risk of Serious Cardiovascular Outcomes in Statin-Intolerant Patients

Related Content

The American College of Cardiology has released a workbook on remote patient management (RPM), which aims to guide CV care professionals on definitions, clinical uses, benefits and limitations.
News | ACC
American College of Cardiology, ACC, Releases Guide to Remote Patient Management

July 31, 2024 — The American College of Cardiology (ACC) has announced its release of the ACC Remote Patient Management ...

Home July 31, 2024
Home
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM).
News | ACC
Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups

July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...

Home July 10, 2024
Home
The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM).
News | ACC
American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines

May 9, 2024 — The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new ...

Home May 09, 2024
Home
Results from the IVUS-DCB trial were recently presented at the American College of Cardiology Annual Scientific Session, ACC.24.
News | ACC
Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...

Home April 11, 2024
Home
The Minneapolis Heart Institute Foundation (MHIF) is presenting data on trends in ST-elevation myocardial infarction (STEMI) at the American College of Cardiology’s Annual Scientific Session (ACC.24). An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovascular disease.
News | ACC
Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks

April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST ...

Home April 06, 2024
Home
In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization, the American College of Cardiology (ACC) has planned a full range of educational programming, special events and peer networking scheduled throughout the April 6-8 event in Atlanta, GA. 
Feature | ACC | Christine Book
American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization ...

Home April 03, 2024
Home
Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II-III obstructive hypertrophic cardiomyopathy at the American College of Cardiology (ACC) Annual Scientific Session & Expo, ACC.24, taking place April 6-8, 2024 in Atlanta, Georgia.
News | ACC
Bristol Myers Squibb to Present Data on CAMZYOS (mavacamten) for obstructive hypertrophic cardiomyopathy (HCM) at American College of Cardiology Annual Scientific Session, ACC.24

March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II ...

Home March 26, 2024
Home
Here is a look at the education and special events planned for the ACC24 73rd Annual Scientific Session & Expo, April 6-8 in Atlanta
Feature | ACC | By Melinda Taschetta-Millane
American College of Cardiology (ACC24) Show Preview: Advancing Cardiovascular Care for All

The American College of Cardiology (ACC) has announced key educational and programming highlights for its ACC 73rd ...

Home March 25, 2024
Home
Association Between Prognostic Implications of Platelet FCɣRIIA (PFCG) and Treatment Strategy for Myocardial Infarction
News | ACC
Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)

March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal ...

Home March 21, 2024
Home
The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd Annual Scientific Session & Expo, ACC.24, including U.S. Food and Drug Administration Commissioner Robert M. Califf, MD, MACC, among a host of highly-regarded cardiovascular thought leaders and practitioners during the April 6-8 meeting in Atlanta, GA.
News | ACC
FDA Commissioner, Host of Cardiovascular Leaders to Offer Keynote Addresses at ACC.24

March 7, 2024 — The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd ...

Home March 07, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now